Piper Jaffray Aktie
WKN: A0BLBX ISIN: US7240781002
aktueller Kurs:
65,00 EUR
0,25 EUR
Veränderung in %:
0,39 %
weitere Analysen einblenden

Piper Jaffray Convenes Top Leaders in Healthcare for Annual Heartland Summit

Dienstag, 18.06.19 16:00
Piper Jaffray Convenes Top Leaders in Healthcare for Annual Heartland Summit
Bildquelle: fotolia.com

Piper Jaffray Companies (NYSE: PJC), a leading investment bank and institutional securities firm with one of Wall Street’s most active and awarded healthcare practices, will host the 7th annual Heartland Summit on June 20, 2019 in Minneapolis.

The Piper Jaffray Heartland Summit is an exclusive annual gathering of CEOs, policy-makers and investors representing every major sector within healthcare. This year’s event will feature 13 panel discussions with 37 of the healthcare industry’s most prominent leaders weighing in on the biggest topics shaping healthcare.

“The Heartland Summit has become the premier event for CEOs and healthcare leaders to gather and discuss the more significant areas of challenge, growth and opportunity in healthcare. Perhaps more importantly, it has become a place where trusted relationships among healthcare leaders are developed, and we at Piper Jaffray are honored to help facilitate these conversations and connections,” said Chad Abraham, chief executive officer at Piper Jaffray.

The distinguished group of healthcare leaders at this year’s Heartland Summit includes:

  • Bahram Akradi, Founder, Chairman & CEO of LIFE TIME
  • Abdulla Al Shamsi, Head of Healthcare at Mubadala Investment Company
  • Cory Alexander, EVP of Corporate Affairs at UnitedHealth Group Incorporated
  • Jack Bailey, President of US Pharmaceuticals at GlaxoSmithKline plc
  • George Barrett, former Chairman & CEO of Cardinal Health, Inc.
  • Robert Bradway, Chairman & CEO of Amgen, Inc.
  • Giovanni Caforio, M.D., Chairman & CEO of Bristol-Myers Squibb
  • Mark Castaneda, CFO & Treasurer of Tilray, Inc.
  • Jeff Chen, M.D., Executive Director at UCLA Cannabis Research Initiative
  • Andy Conrad, CEO of Verily Life Sciences LLC
  • Scott Drake, President & CEO of ViewRay, Inc.
  • Ken Ehlert, Chief Scientific Officer of UnitedHealth Group Incorporated
  • Stacy Enxing Seng, Venture Partner at Lightstone Ventures
  • Vincent Forlenza, Chairman & CEO of Becton Dickinson & Company
  • Mark Ganz, CEO & President of Cambia Health Solutions, Inc.
  • Jason Gorevic, CEO & Director of Teledoc Health, Inc.
  • Alex Gorsky, Chairman & CEO of Johnson & Johnson
  • Alexander Hardy, CEO of Genentech, Inc.
  • Sam Hazen, CEO of HCA Healthcare, Inc.
  • Sami Inkinen, Founder & CEO of Virta Health, Inc.
  • Bret Jorgensen, Chairman & CEO of MDVIP Inc.
  • Dave King, Chairman, CEO & President at Laboratory Corporation of America Holdings
  • Kyle Kingsley, M.D., Chairman & CEO of Vireo Health International Inc.
  • Abhijeet Lele, Managing Director, Life Sciences at Temasek Holdings
  • Kevin Lobo, Chairman & CEO of Stryker Corporation
  • Mike Mahoney, Chairman & CEO of Boston Scientific Corporation
  • William McKeon, President & CEO of Texas Medical Center
  • Steve Oesterle, M.D., NEA, Former SVP of Medicine and technology at Medtronic
  • James Park, Co-Founder, Chairman & CEO of FitBit, Inc.
  • Erik Paulsen, Former U.S. House of Representatives
  • John Prince, CEO of OptumRx, Inc.
  • Steve Rusckowski, Chairman, President & CEO of Quest Diagnostics Incorporated
  • Kevin Sayer, Chairman, President & CEO of DexCom, Inc.
  • Stephen Ubl, President & CEO of Pharmaceutical Research and Manufacturers of America (PhRMA)
  • Grant Verstandig, Founder, CEO & Co-Head of Product at Rally Health, Inc., Chief Digitial Officer at UnitedHealth Group, Inc.
  • Penny Wheeler, M.D., President & CEO, Allina Health
  • Scott Whitaker, President & CEO of Advanced Medical Technology Associations
  • Dave Wichmann, CEO of UnitedHealth Group Incorporated

Follow the conversation using the event hashtag #PJCHeartland.

Follow Piper Jaffray: LinkedIn | Facebook | Twitter

Company and investor participation in the conference is by invitation only. Clients interested in attending should contact their Piper Jaffray representative. General and research-related media inquiries should be directed to analystmediarelations@pjc.com. All other media inquiries should be directed to Pamela Steensland at pamela.k.steensland@pjc.com.

Information as of June 18, 2019. Subject to change.

Piper Jaffray Companies (NYSE: PJC) is a leading investment bank and institutional securities firm driven to help clients Realize the Power of Partnership®. Securities brokerage and investment banking services are offered in the U.S. through Piper Jaffray & Co., member SIPC and FINRA; in Europe through Piper Jaffray Ltd., authorized and regulated by the U.K. Financial Conduct Authority; and in Hong Kong through Piper Jaffray Hong Kong Limited, authorized and regulated by the Securities and Futures Commission. Asset management products and services are offered through five separate investment advisory affiliates―U.S. Securities and Exchange Commission (SEC) registered Advisory Research, Inc., Piper Jaffray Investment Management LLC, PJC Capital Partners LLC and Piper Jaffray & Co., and Guernsey-based Parallel General Partners Limited, authorized and regulated by the Guernsey Financial Services Commission.

Follow Piper Jaffray: LinkedIn | Facebook | Twitter

© 2019 Piper Jaffray Companies. 800 Nicollet Mall, Suite 1000, Minneapolis, Minnesota 55402-7036

Quelle: Business Wire

Hier geht's zur Aktien-Startseite


Deutsche Bank X-markets: Alle Derivate

News und Analysen

Piper Jaffray Completes 38th Semi-Annual Generation Z Survey of 9,500 U.S. Teens

MINNEAPOLIS – Piper Jaffray Companies (NYSE: PJC), a leading investment bank and institutional securities firm, completed its 38th semi-annual Taking Stock With Teens® survey, which highlights ...weiterlesen

Seite: 1 | 2 |


Im Fokus

Aktueller Chart
  • +457% seit Aktienbrief-Erstempfehlung!
  • Gegessen und getrunken wird immer!
  • Jetzt kostenlose Analyse sichern!


Dividendenrendite Dax-Aktien 2019

Rang: 30

Name: Wirecard

Dividende pro Aktie: 0,20 Euro

Veränderung Vorjahr: +11%

Dividenden-Rendite: 0,1%


P.S.: Auch bei Dividenden-Aktien gilt, das Spreu vom Weizen zu trennen. Im boerse.de-Aktienbrief erfahren Sie beispielsweise nur die langfristig besten Dividenden-Aktien der Welt. Eine Gratis-Ausgabe vom Aktienbrief gibt´s hier.

Der Backtest: Handelsstrategien auf dem Prüfstand

Der Backtest: Handelsstrategien auf dem Prüfstand
Ein Backtest – auf deutsch: Rücktest oder auch Rückvergleich – ist ein Prozess zur Bewertung eines Modells. Hierzu werden die Regeln einer vorhandenen Strategie auf historische Daten angewendet. Dies erfolgt entweder mit einer speziell hierfür entwickelten Software oder durch eigene Programmierungen.
© 1994-2019 by boerse.de - Quelle für Kurse und Daten: ARIVA.DE AG - boerse.de übernimmt keine Gewähr